Related Experiment Videos
[The effect of anisodaminum and dexamethasone on microcirculation, TNF, LPO and pathology in MODS]
1Department of General Surgery, General Hospital, Commission of Science, Technology and Industry for National Defense of the People's Republic of China, Beijing.
Abstract:
In order to evaluate the effect of anisodaminum and dexamethasone to the microcurculation, TNF, LPO and pathology in MODS, we first established MODS model using cecem ligature and perfuration of rabbit then divided it into four groups: anisodaminum, dexamethasone, combined anisodaminum and dexamethasone and control. After used the corresponding drugs we observed the change of microcirculation, TNF, LPO and organ pathology. The result showed that microcirculation improved, the serum level of TNF and LPO decreased, and the pathomorphological changes lessensed. It is suggested that the combined use of anisodaminum and dexamethasone may be a new way for treating MODS.
Insights
Anisodamine and dexamethasone combination therapy improved microcirculation and reduced inflammatory markers in a rabbit model of multiple organ dysfunction syndrome (MODS). This suggests a potential new treatment strategy for MODS.
Area of Science:
- Pharmacology
- Pathology
- Immunology
Context:
- Multiple Organ Dysfunction Syndrome (MODS) is a critical condition with high mortality.
- Current treatments for MODS have limitations.
- Understanding the pathophysiology of MODS is crucial for developing effective therapies.
Purpose:
- To evaluate the therapeutic effects of anisodamine and dexamethasone, individually and in combination, on microcirculation, tumor necrosis factor (TNF), lipid peroxidation (LPO), and organ pathology in a rabbit model of MODS.
Summary:
- A rabbit model of MODS was established and divided into four groups: anisodamine, dexamethasone, combined anisodamine and dexamethasone, and control.
- Treatment with anisodamine and dexamethasone led to improved microcirculation.
- Serum levels of TNF and LPO were decreased, and pathological organ damage was reduced in the treated groups, particularly the combination group.
Impact:
- Combined anisodamine and dexamethasone demonstrated a synergistic effect in mitigating MODS.
- This combination therapy shows promise as a novel treatment approach for MODS.
- Further research may validate this combination for clinical application in MODS patients.